CorMedix Inc. CRMD

US Pharmaceuticals

$5.45 ▼ -0.37% ($-0.02)

🔥 High Short Interest 📅 Earnings This Week

Open $5.50

Prev Close $5.47

Day Range $5.43 – $5.69

52W Range $5.10 – $13.02

Market Cap $426.36M

P/E (TTM) 2.28

Beta 1.55

EPS (TTM) $2.10

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2010-03-25
Shares Out.	77,940,000
Website	cormedix.com/ ↗
Phone	13026365400
Employees	191
Revenue	$101.9M
Gross Profit	$77.1M
Net Income	$26.0M
Free Cash Flow	$250.4M
Total Assets	$904.1M
Total Liabilities	$443.2M
Equity	$460.8M

About CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

CorMedix Inc. is a publicly traded company under the ticker symbol CRMD on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.